AML blasts from patients that achieve CR and never relapse (red) are more primed than AML blast from patients who don't achieve CR (blue). Patients that achieve CR but later relapse are also more primed than refractory patients. Normal HSCs (orange) are intermediately primed and may set the therapeutic window.